Crossmark

Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker

Crossref DOI link: https://doi.org/10.1186/s12967-020-02498-3

Published Online: 2020-09-04

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Byrling, Johannes

Kristl, Theresa

Hu, Dingyuan

Pla, Indira

Sanchez, Aniel

Sasor, Agata

Andersson, Roland

Marko-Varga, György

Andersson, Bodil https://orcid.org/0000-0001-5591-0659
Funding

Funding for this research was provided by:

This research work was supported by government grant for clinical research (http://www.skane.se/fou/alf).

Cancerfonden

Erik and Angelica Sparres research foundation
License Information

Text and Data Mining valid from 2020-09-04

Version of Record valid from 2020-09-04
More Information

Article History

Received: 18 April 2020

Accepted: 21 August 2020

First Online: 4 September 2020

Ethics approval and consent to participate

: The study was approved by the Regional Human Ethics Committee in Lund Sweden (2015/392).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below